ArticleFrontiers in medicine2024

Ustekinumab affects myofibroblast metabolism to alleviate intestinal fibrosis by targeting KDELC1 in Crohn's disease through multi-machine learning combined with single-cell sequencing analysis.

Su Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.